Your browser doesn't support javascript.
loading
Arpin is critical for phagocytosis in macrophages and is targeted by human rhinovirus.
Jubrail, Jamil; Africano-Gomez, Kshanti; Herit, Floriane; Mularski, Anna; Bourdoncle, Pierre; Oberg, Lisa; Israelsson, Elisabeth; Burgel, Pierre-Regis; Mayer, Gaell; Cunoosamy, Danen M; Kurian, Nisha; Niedergang, Florence.
  • Jubrail J; Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
  • Africano-Gomez K; Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
  • Herit F; Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
  • Mularski A; Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
  • Bourdoncle P; Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
  • Oberg L; Translational Science and Experimental Medicine, Research and Early Development, Respiratory Inflammation and Autoimmunity, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Israelsson E; Translational Science and Experimental Medicine, Research and Early Development, Respiratory Inflammation and Autoimmunity, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Burgel PR; Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR 8104, Paris, France.
  • Mayer G; Department of Pneumology, Hospital Cochin, AP-HP, Paris, France.
  • Cunoosamy DM; Late-stage development, Respiratory, Inflammation and Autoimmunity (RIA), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Kurian N; Translational Science and Experimental Medicine, Research and Early Development, Respiratory Inflammation and Autoimmunity, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Niedergang F; Respiratory Inflammation and Autoimmune Precision Medicine Unit, Precision Medicine, Oncology R&D, AstraZeneca, Gothenburg, Sweden.
EMBO Rep ; 21(1): e47963, 2020 01 07.
Article en En | MEDLINE | ID: mdl-31721415
ABSTRACT
Human rhinovirus is a causative agent of severe exacerbations of chronic obstructive pulmonary disease (COPD). COPD is characterised by an increased number of alveolar macrophages with diminished phagocytic functions, but how rhinovirus infection affects macrophage function is still unknown. Here, we describe that human rhinovirus 16 impairs bacterial uptake and receptor-mediated phagocytosis in macrophages. The stalled phagocytic cups contain accumulated F-actin. Interestingly, we find that human rhinovirus 16 downregulates the expression of Arpin, a negative regulator of the Arp2/3 complex. Importantly, re-expression of the protein rescues defective internalisation in human rhinovirus 16-treated cells, demonstrating that Arpin is a key factor targeted to impair phagocytosis. We further show that Arpin is required for efficient uptake of multiple targets, for F-actin cup formation and for successful phagosome completion in macrophages. Interestingly, Arpin is recruited to sites of membrane extension and phagosome closure. Thus, we identify Arpin as a central actin regulator during phagocytosis that it is targeted by human rhinovirus 16, allowing the virus to perturb bacterial internalisation and phagocytosis in macrophages.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fagocitosis / Rhinovirus Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fagocitosis / Rhinovirus Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article